77337-73-6 | Acamprosate Calcium

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$94.00	$66.00
1g	98%	in stock	$126.00	$88.00

Description

• Catalog Number: AB70369
• Chemical Name: Acamprosate Calcium
• CAS Number: 77337-73-6
• Molecular Formula: C10H20CaN2O8S2
• Molecular Weight: 400.4824
• MDL Number: MFCD00886588
• SMILES: CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
• NSC Number: 759186

Computed Properties

• Complexity: 202
• Covalently-Bonded Unit Count: 3
• Heavy Atom Count: 23
• Hydrogen Bond Acceptor Count: 8
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 6

Literature

• Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.

  Psychopharmacology 20130701

• New pharmacological treatment strategies for relapse prevention.

  Current topics in behavioral neurosciences 20130101

• Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.

  Biological psychiatry 20121115

• Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: the effects on immediate-early gene expression in the rat prefrontal cortex.

  Neuropharmacology 20121101

• Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test.

  Progress in neuro-psychopharmacology & biological psychiatry 20121001

• The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study.

  Journal of clinical psychopharmacology 20121001

• The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.

  Addiction biology 20120901

• The cost-effectiveness of tailored, postal feedback on general practitioners' prescribing of pharmacotherapies for alcohol dependence.

  Drug and alcohol dependence 20120801

• Trajectory analyses in alcohol treatment research.

  Alcoholism, clinical and experimental research 20120801

• Does session attendance by a supportive significant other predict outcomes in individual treatment for alcohol use disorders?

  Alcoholism, clinical and experimental research 20120701

• Pharmacotherapy for adolescent alcohol use disorder.

  CNS drugs 20120701

• Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.

  Neuropharmacology 20120601

• Strategies for evaluating the economic value of drugs in alcohol dependence treatment.

  Drug and alcohol dependence 20120501

• Influence of ionization source design on matrix effects during LC-ESI-MS/MS analysis.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120415

• Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.

  Alcoholism, clinical and experimental research 20120301

• Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.

  Alcohol (Fayetteville, N.Y.) 20120301

• Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.

  Alcoholism, clinical and experimental research 20120301

• Acamprosate modulates experimental autoimmune encephalomyelitis.

  Inflammopharmacology 20120201

• A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.

  Bipolar disorders 20120201

• Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20120101

• Pharmacogenetics of alcoholism: a clinical neuroscience perspective.

  Pharmacogenomics 20120101

• An open-label naturalistic pilot study of acamprosate in youth with autistic disorder.

  Journal of child and adolescent psychopharmacology 20111201

• [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].

  Ugeskrift for laeger 20111128

• The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.

  Drug and alcohol dependence 20111101

• Opioid antagonists for the treatment of alcohol dependence.

  American family physician 20111101

• An open-label trial of acamprosate in the treatment of pathological gambling.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20111101

• Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.

  The pharmacogenomics journal 20111001

• A LC-MS analysis of acamprosate from human plasma: pharmacokinetic application.

  Drug testing and analysis 20111001

• Acamprosate-responsive brain sites for suppression of ethanol intake and preference.

  American journal of physiology. Regulatory, integrative and comparative physiology 20111001

• Circadian and acamprosate modulation of elevated ethanol drinking in mPer2 clock gene mutant mice.

  Chronobiology international 20111001

• [Good effect of drug therapy against alcoholism].

  Lakartidningen 20111001

• Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial.

  Psychiatry research 20110815

• A literature review of cost-benefit analyses for the treatment of alcohol dependence.

  International journal of environmental research and public health 20110801

• Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.

  The Journal of nervous and mental disease 20110701

• How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatment.

  Neurophysiologie clinique = Clinical neurophysiology 20110701

• Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.

  Addictive behaviors 20110601

• Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence.

  Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 20110601

• Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.

  Behavioural pharmacology 20110601

• Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.

  The American journal of managed care 20110601

• Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110501

• Marked reduction of heavy drinking did not reduce nicotine use over 1 year in a clinical sample of alcohol-dependent patients.

  Pharmacopsychiatry 20110501

• A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.

  Addictive behaviors 20110301

• Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.

  Alcoholism, clinical and experimental research 20110301

• Addiction treatment: level of care determination.

  Primary care 20110301

• Effectiveness of acamprosate in the treatment of alcohol dependence.

  American family physician 20110301

• Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1.

  Neuroscience letters 20110225

• Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence.

  Journal of consulting and clinical psychology 20110201

• Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial.

  The International journal of eating disorders 20110101

• Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

• Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

• Does family history of alcoholism moderate naltrexone's effects on alcohol use?

  Journal of studies on alcohol and drugs 20110101

• Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

• Pharmacological treatment of insomnia in alcohol recovery: a systematic review.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

• Medical treatment of alcohol dependence: a systematic review.

  International journal of psychiatry in medicine 20110101

• [Cochrane review about the effect of acamprosate].

  Ugeskrift for laeger 20101206

• Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.

  Alcoholism, clinical and experimental research 20101201

• Acamprosate calcium as augmentation therapy for anxiety disorders.

  The Annals of pharmacotherapy 20101201

• Brief report: acamprosate in fragile X syndrome.

  Journal of autism and developmental disorders 20101101

• Network support as a prognostic indicator of drinking outcomes: the COMBINE Study.

  Journal of studies on alcohol and drugs 20101101

• Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats.

  Biological psychiatry 20101015

• Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.

  Archives of general psychiatry 20101004

• Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence.

  Journal of substance abuse treatment 20101001

• Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

  Alcoholism, clinical and experimental research 20101001

• Acamprosate for alcohol dependence.

  The Cochrane database of systematic reviews 20100908

• Acamprosate modulates alcohol-induced hippocampal NMDA receptors and brain microsomal Ca2+-ATPase but induces oxidative stress in rat.

  The Journal of membrane biology 20100901

• Gambling on acamprosate: a case report.

  The Journal of clinical psychiatry 20100901

• Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers.

  Therapeutic drug monitoring 20100801

• The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study.

  Medical care 20100501

• The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation.

  Journal of substance abuse treatment 20100401

• Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective.

  Medical care 20100401

• Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.

  Psychiatric services (Washington, D.C.) 20100401

• Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study.

  Drug and alcohol dependence 20100301

• Acamprosate.

  Expert opinion on drug metabolism & toxicology 20100301

• Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.

  CNS & neurological disorders drug targets 20100301

• Pharmacotherapies for alcoholism: the old and the new.

  CNS & neurological disorders drug targets 20100301

• Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate.

  Alcoholism, clinical and experimental research 20100101

• Glycine receptors involved in acamprosate's modulation of accumbal dopamine levels: an in vivo microdialysis study.

  Alcoholism, clinical and experimental research 20100101

• The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.

  Expert opinion on drug safety 20100101

• The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy.

  The American journal on addictions 20100101

• Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20100101

• Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy.

  Current pharmaceutical design 20100101

• [Impact of functional social support for abstinence after inpatient detoxification].

  Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20100101

• Retrospective review of acute acamprosate exposures to a poison control system.

  The American journal on addictions 20100101

• Clinical predictors of outcome from an Australian pharmacological relapse prevention trial.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20100101

• Comparison of healthcare utilization among patients treated with alcoholism medications.

  The American journal of managed care 20100101

• The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin.

  Brain research 20091211

• Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.

  Drug and alcohol dependence 20091201

• Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.

  Prescrire international 20091001

• Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study.

  Alcoholism, clinical and experimental research 20090901

• Cue-induced alcohol-seeking behaviour is reduced by disrupting the reconsolidation of alcohol-related memories.

  Psychopharmacology 20090801

• The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial.

  Psychopharmacology 20090701

• Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.

  Addiction biology 20090701

• [Interaction between Saint Johns Wort and alcohol deterrents?].

  Lakartidningen 20090701

• Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats.

  Psychopharmacology 20090601

• Treatment of alcohol dependence.

  The Ceylon medical journal 20090601

• The implications of medication development in the treatment of substance use disorders in developing countries.

  Current opinion in psychiatry 20090501

• Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.

  Alcoholism, clinical and experimental research 20090401

• Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.

  Drug and alcohol dependence 20090101

• The state of pharmacotherapy for the treatment of alcohol dependence.

  Journal of substance abuse treatment 20090101

• Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.

  Psychotherapy and psychosomatics 20090101

• Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.

  Addictive behaviors 20090101

• Pharmacokinetics of acamprosate calcium in healthy Chinese subjects after oral administration of three dosage levels.

  Arzneimittel-Forschung 20090101

• Successful acamprosate treatment of alcohol dependence in schizophrenia.

  Schizophrenia research 20081201

• The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.

  European journal of pharmacology 20081119

• Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20081101

• Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice.

  Alcoholism, clinical and experimental research 20081101

• Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.

  Journal of studies on alcohol and drugs 20081101

• Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.

  Current drug abuse reviews 20081101

• Effects of naltrexone and acamprosate on alcohol-induced NGFI-A expression in mouse brain.

  Neurochemical research 20081001

• Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats.

  Alcoholism, clinical and experimental research 20081001

• Preserved DNA from past clinical trials yields new information about a subtype of alcoholism.

  Current psychiatry reports 20081001

• Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.

  Archives of general psychiatry 20081001

• Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice.

  Physiology & behavior 20080903

• Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.

  The international journal of neuropsychopharmacology 20080901

• Relationship between medication adherence and treatment outcomes: the COMBINE study.

  Alcoholism, clinical and experimental research 20080901

• An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care.

  Annals of family medicine 20080901

• Aminomethylpiperazines as selective urotensin antagonists.

  Bioorganic & medicinal chemistry letters 20080815

• Analysis of acamprosate in beagle dog plasma by LC-MS-MS.

  Archives of pharmacal research 20080801

• Acamprosate: recent findings and future research directions.

  Alcoholism, clinical and experimental research 20080701

• Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

  Addiction (Abingdon, England) 20080601

• Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets.

  Archives of pharmacal research 20080601

• [Pharmacotherapy of alcohol dependence].

  MMW Fortschritte der Medizin 20080519

• [Alcohol dependence: diagnosis and treatment].

  La Revue de medecine interne 20080401

• Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.

  Addiction biology 20080301

• The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.

  Drug and alcohol dependence 20080301

• A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration.

  Addiction biology 20080301

• Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference.

  Neuroscience letters 20080206

• Effects of acamprosate on neuronal receptors and ion channels expressed in Xenopus oocytes.

  Alcoholism, clinical and experimental research 20080201

• An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

  Archives of general psychiatry 20080201

• From the neurobiologic basis of alcohol dependency to pharmacologic treatment strategies: bridging the knowledge gap.

  Southern medical journal 20080201

• Substance abuse and schizophrenia: pharmacotherapeutic intervention.

  Journal of substance abuse treatment 20080101

• Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

  Biochemical pharmacology 20080101

• A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20080101

• NMDA receptor blockade: a novel avenue for tobacco intervention?

  Medical hypotheses 20080101

• Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

  Journal of studies on alcohol and drugs 20080101

• Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.

  Journal of psychopharmacology (Oxford, England) 20080101

• Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.

  The American journal on addictions 20080101

• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20080101

• [Pharmacological review of alcoholic dependence treatment].

  Vertex (Buenos Aires, Argentina) 20080101

• The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.

  The American journal of drug and alcohol abuse 20080101

• Effectiveness of sequential combined treatment in comparison with treatment as usual in preventing relapse in alcohol dependence.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20080101

• [Recent results in relaps prevention of alcoholism with Disulfiram].

  Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20080101

• New therapies for alcohol dependence open options for office-based treatment.

  JAMA 20071205

• Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats.

  Psychopharmacology 20071201

• Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.

  Expert review of neurotherapeutics 20071101

• Psychometrics of the Drinker Inventory of Consequences (DrInC).

  Addictive behaviors 20070801

• The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070701

• Acamprosate and primitive reflexes.

  The Annals of pharmacotherapy 20070401

• Measuring economic outcomes of alcohol treatment using the Economic Form 90.

  Journal of studies on alcohol and drugs 20070301

• Emerging approaches to managing alcohol dependence.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

• Improving adherence in patients with alcohol dependence: a new role for pharmacists.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

• Alcohol dependence and pharmacologic treatment. Introduction.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

• Schizophrenia and co-occurring substance use disorder.

  The American journal of psychiatry 20070301

• Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice.

  Addiction biology 20070301

• Influence of age at drinking onset on the alcohol deprivation effect and stress-induced drinking in female rats.

  Pharmacology, biochemistry, and behavior 20070201

• Preclinical and clinical pharmacology of alcohol dependence.

  Fundamental & clinical pharmacology 20070201

• [Neurobiological mechanisms and pharmacological treatment options for alcohol craving].

  Fortschritte der Neurologie-Psychiatrie 20070101

• [Pharmacological relapse prevention in alcohol and tobacco dependence].

  Der Internist 20070101

• Glutamate-modulating drugs & the treatment of mental disorders.

  Journal of psychosocial nursing and mental health services 20070101

• Therapeutics for alcoholism: what's the future?

  Drug and alcohol review 20070101

• Consideration of acamprosate for treatment of amyotrophic lateral sclerosis.

  Medical hypotheses 20070101

• Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20070101

• Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokers.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20070101

• Treatment of tinnitus with acamprosate.

  Progress in brain research 20070101

• Somatic configuration: a model for an integrated approach to the understanding of disease.

  Substance use & misuse 20070101

• The application of machine learning techniques as an adjunct to clinical decision making in alcohol dependence treatment.

  Substance use & misuse 20070101

• [Drugs against alcohol abuse].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20061214

• New pharmacological approaches for the treatment of alcoholism.

  Expert opinion on pharmacotherapy 20061201

• Trends in the adoption of medications for alcohol dependence.

  Journal of clinical psychopharmacology 20061201

• Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms.

  Neurotoxicity research 20061201

• Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.

  Addictive behaviors 20061101

• Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats.

  Biopharmaceutics & drug disposition 20061001

• Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

  Addiction (Abingdon, England) 20061001

• Choosing the right medication for the treatment of alcoholism.

  Current psychiatry reports 20061001

• Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?

  Expert opinion on pharmacotherapy 20061001

• Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

  Pharmacology & therapeutics 20060901

• Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.

  Alcoholism, clinical and experimental research 20060901

• Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.

  Neuroscience letters 20060814

• Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

  Journal of psychiatric research 20060801

• Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?

  Biological psychiatry 20060701

• Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: part I.

  Journal of psychiatric practice 20060701

• Attenuation of cocaine-induced reinstatement of cocaine conditioned place preference by acamprosate.

  Behavioural pharmacology 20060601

• [Maintaining abstinence after alcohol detoxification].

  La Revue du praticien 20060531

• Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

  JAMA 20060503

• What's new in clinical pharmacology and therapeutics.

  WMJ : official publication of the State Medical Society of Wisconsin 20060501

• Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.

  Yonsei medical journal 20060430

• A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients.

  Alcoholism, clinical and experimental research 20060401

• Tinnitus. Overcoming the noise.

  Mayo Clinic health letter (English ed.) 20060401

• The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.

  Journal of psychiatric practice 20060301

• Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.

  Addiction biology 20060301

• N-methyl-D-aspartate and group I metabotropic glutamate receptors are involved in the expression of ethanol-induced sensitization in mice.

  Behavioural pharmacology 20060201

• New drugs 06, part I.

  Nursing 20060201

• Alcoholism and suicidal behavior: a clinical overview.

  Acta psychiatrica Scandinavica 20060101

• Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20060101

• Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler.

  Drugs 20060101

• Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?

  Journal of addictive diseases 20060101

• Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?

  Addiction biology 20051201

• New alcohol abuse drugs emerging. Anti-craving meds are finally here to treat alcohol dependence, recognized as a disease of the brain.

  Health news (Waltham, Mass.) 20051201

• Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference.

  Neuroscience letters 20051104

• Medications for treating alcohol dependence.

  American family physician 20051101

• The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.

  Journal of studies on alcohol 20051101

• Acamprosate in the treatment of alcohol dependence.

  Expert opinion on pharmacotherapy 20051001

• Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats.

  European journal of pharmacology 20050927

• Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.

  Journal of psychiatric research 20050901

• The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.

  Addiction biology 20050901

• Acamprosate.

  Nursing times 20050901

• Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.

  Alcoholism, clinical and experimental research 20050801

• A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment.

  Pharmacopsychiatry 20050701

• Drug treatment for alcoholism today.

  The Harvard mental health letter 20050701

• Combining treatments for alcoholism: why and how?

  Journal of studies on alcohol. Supplement 20050701

• COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.

  Journal of studies on alcohol. Supplement 20050701

• Choosing pharmacotherapies for the COMBINE Study--process and procedures: an investigational approach to combination pharmacotherapy for the treatment of alcohol dependence.

  Journal of studies on alcohol. Supplement 20050701

• Rationale for combining acamprosate and naltrexone for treating alcohol dependence.

  Journal of studies on alcohol. Supplement 20050701

• The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field.

  Journal of studies on alcohol. Supplement 20050701

• The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050601

• Acamprosate for the treatment of alcohol dependence.

  Clinical therapeutics 20050601

• Repeated-testing of place preference expression for evaluation of anti-craving-drug effects.

  Amino acids 20050501

• New drug released for alcohol dependency.

  Mayo Clinic health letter (English ed.) 20050401

• Acamprosate (Campral) for alcoholism.

  Connecticut medicine 20050401

• Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.

  Psychopharmacology 20050301

• Effect of acamprosate on neonatal excitotoxic cortical lesions in in utero alcohol-exposed hamsters.

  Neuroscience letters 20050210

• Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats.

  Neuroscience letters 20050210

• Acamprosate campral for alcoholism.

  The Medical letter on drugs and therapeutics 20050103

• Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050101

• The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption.

  Nature medicine 20050101

• New drugs: acamprosate calcium and solifenacin succinate.

  Journal of the American Pharmacists Association : JAPhA 20050101

• Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.

  European addiction research 20050101

• Effect of the combined administration of ethanol and acamprosate on rabbit EEG.

  Pharmacological reports : PR 20050101

• Effect of community nurse follow-up when treating alcohol dependence with acamprosate.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20050101

• Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.

  CNS drugs 20050101

• A critical review of pharmacoeconomic studies of acamprosate.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20050101

• Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

  CNS drugs 20050101

• An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20050101

• Clinical characterization of use of acamprosate and naltrexone: data from an addiction center in India.

  The American journal on addictions 20050101

• Pharmacotherapy of alcohol use disorders.

  Substance use & misuse 20050101

• Tinnitus treatment with acamprosate: double-blind study.

  Brazilian journal of otorhinolaryngology 20050101

• Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041101

• Effect of neramexane on ethanol dependence and reinforcement.

  European journal of pharmacology 20041025

• Recent advances in the pharmacotherapy of alcoholism.

  Current psychiatry reports 20041001

• The mosaic of addiction.

  The American journal of psychiatry 20041001

• Ask the doctor. I need to quit drinking, but don't think I can do it on my own. Can I use a drug like Antabuse even though I have heart disease?

  Harvard heart letter : from Harvard Medical School 20041001

• Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040801

• Biphasic effect of acamprosate on NMDA but not on GABAA receptors in spontaneous rhythmic activity from the isolated neonatal rat respiratory network.

  Neuropharmacology 20040701

• Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

  Addiction (Abingdon, England) 20040701

• Synthesis and assessment of [11C]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography.

  Nuclear medicine and biology 20040701

• The NMDA receptor channel blocker memantine and opioid receptor antagonist naltrexone inhibit the saccharin deprivation effect in rats.

  Behavioural pharmacology 20040701

• Alcohol effects during acamprosate treatment: a dose-response study in humans.

  Alcoholism, clinical and experimental research 20040701

• Hypothalamic-pituitary-adrenal system regulation in recently detoxified alcoholics is not altered by one week of treatment with acamprosate.

  Pharmacopsychiatry 20040501

• [The pharmacologic treatment of the alcohol dependence].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20040501

• Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.

  Psychiatry and clinical neurosciences 20040201

• NR2B subunit selective NMDA antagonists inhibit neurotoxic effect of alcohol-withdrawal in primary cultures of rat cortical neurones.

  Neurochemistry international 20040101

• The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.

  Alcoholism, clinical and experimental research 20040101

• Improvement in quality of life after treatment for alcohol dependence with acamprosate and psychosocial support.

  Alcoholism, clinical and experimental research 20040101

• Acamprosate in alcohol dependence: a randomized controlled efficacy study in a standard clinical setting.

  Journal of studies on alcohol 20040101

• A comparison of two intensities of psychosocial intervention for alcohol dependent patients treated with acamprosate.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20040101

• Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.

  Neuropsychobiology 20040101

• A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20040101

• Combined therapy: what does acamprosate and naltrexone combination tell us?

  Alcohol and alcoholism (Oxford, Oxfordshire) 20040101

• Pragmatic trials and the ARES study.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20040101

• New drug to treat alcoholism.

  FDA consumer 20040101

• Acamprosate involvement in triacylglycerol hydrolysis and transacylation with cholesterol in chronically ethanol-drinking rats.

  Journal of basic and clinical physiology and pharmacology 20040101

• Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20031201

• Does acamprosate improve reduction of drinking as well as aiding abstinence?

  Journal of psychopharmacology (Oxford, England) 20031201

• [Acamprosate--new preclinical research aspects].

  MMW Fortschritte der Medizin 20031009

• [Advances in the treatment of alcohol dependence: pharmacological relapse prevention].

  MMW Fortschritte der Medizin 20031009

• Acamprosate blocks the increase in dopamine extracellular levels in nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.

  Naunyn-Schmiedeberg's archives of pharmacology 20031001

• [Psychosocial treatment plus drug prophylaxis. Fewer recurrences after alcohol withdrawal].

  MMW Fortschritte der Medizin 20030904

• Efficacy of acamprosate in the treatment of alcohol-dependent outpatients.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20030901

• New pharmacotherapies for alcohol dependence: are they being used and what do they cost?

  The Medical journal of Australia 20030818

• Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030801

• The effect of acamprosate on the development of morphine-induced behavioral sensitization in rats.

  Behavioural pharmacology 20030701

• Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods.

  Alcoholism, clinical and experimental research 20030701

• Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.

  Alcoholism, clinical and experimental research 20030701

• Acamprosate and its efficacy in treating alcohol dependent adolescents.

  European child & adolescent psychiatry 20030601

• Acamprosate does not induce a conditioned place preference and reveals no state-dependent effects in this paradigm.

  Progress in neuro-psychopharmacology & biological psychiatry 20030601

• Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.

  Journal of clinical psychopharmacology 20030601

• A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.

  Addiction biology 20030601

• [Preventing recurrence after alcohol withdrawal treatment with drugs. Reducing the drive to drink].

  MMW Fortschritte der Medizin 20030508

• Physicians' opinions about medications to treat alcoholism.

  Addiction (Abingdon, England) 20030501

• Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent patients.

  European addiction research 20030401

• Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods.

  Alcoholism, clinical and experimental research 20030301

• Local acamprosate modulates dopamine release in the rat nucleus accumbens through NMDA receptors: an in vivo microdialysis study.

  Naunyn-Schmiedeberg's archives of pharmacology 20030201

• [Deficits in preventing recurrence in alcoholic patients. Withdrawal--and immediately back to the bottle].

  MMW Fortschritte der Medizin 20030116

• Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.

  Archives of general psychiatry 20030101

• The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine.

  British journal of pharmacology 20030101

• Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20030101

• Acamprosate.

  Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism 20030101

• Acamprosate for the adjunctive treatment of alcohol dependence.

  The Annals of pharmacotherapy 20030101

• Research advances in the understanding and treatment of addiction.

  The American journal on addictions 20030101

• The anti-craving taurine derivative acamprosate: failure to extinguish morphine conditioned place preference.

  Advances in experimental medicine and biology 20030101

• Pharmacology of acamprosate: an overview.

  CNS drug reviews 20030101

• [Acamprosate (Aotal): could adverse effects upset the treatment of alcohol dependence?].

  Therapie 20030101

• [Neural basis of alcohol dependence].

  Duodecim; laaketieteellinen aikakauskirja 20030101

• [Drug therapy of alcohol dependence--a critical review].

  Duodecim; laaketieteellinen aikakauskirja 20030101

• Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.

  The American journal on addictions 20030101

• Current pharmacotherapies of alcoholism: a U.S. perspective.

  The American journal on addictions 20030101

• Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.

  The American journal on addictions 20030101

• Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors.

  Alcoholism, clinical and experimental research 20021201

• Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?

  The Australian and New Zealand journal of psychiatry 20021001

• Disposition of acamprosate in the rat: influence of probenecid.

  Biopharmaceutics & drug disposition 20021001

• Acamprosate reduces context-dependent ethanol effects.

  Psychopharmacology 20021001

• A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021001

• Acamprosate, MK-801, and ifenprodil inhibit neurotoxicity and calcium entry induced by ethanol withdrawal in organotypic slice cultures from neonatal rat hippocampus.

  Alcoholism, clinical and experimental research 20021001

• The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.

  Alcoholism, clinical and experimental research 20021001

• New pharmacotherapies for alcohol dependence.

  The Medical journal of Australia 20020715

• Acamprosate decreases the induction of tolerance and physical dependence in morphine-treated mice.

  European journal of pharmacology 20020607

• Effects of acamprosate and some polyamine site ligands of NMDA receptor on short-term memory in rats.

  European journal of pharmacology 20020524

• Acamprosate has no effect on NMDA-induced toxicity but reduces toxicity induced by spermidine or by changing the medium in organotypic hippocampal slice cultures from rat.

  Alcoholism, clinical and experimental research 20020501

• [Long-term treatment of alcohol dependance].

  Gastroenterologie clinique et biologique 20020501

• [Acamprosate and psychosocial intervention. An integrative treatment approach for prevention of alcohol dependent patients in Switzerland].

  Praxis 20020424

• Drug treatments for alcoholism.

  The Harvard mental health letter 20020401

• Potential neuroprotective effects of acamprosate.

  Alcoholism, clinical and experimental research 20020401

• Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release.

  European journal of pharmacology 20020215

• Central nervous system mechanisms in alcohol relapse.

  Alcoholism, clinical and experimental research 20020201

• Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20020101

• Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.

  Drugs in R&D 20020101

• Acamprosate.

  Drugs in R&D 20020101

• Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?

  Alcohol and alcoholism (Oxford, Oxfordshire) 20020101

• Interactions between taurine and ethanol in the central nervous system.

  Amino acids 20020101

• Addiction medicine for the primary care physician.

  The Journal of the Oklahoma State Medical Association 20011101

• Effects of acamprosate on sensitization to the locomotor-stimulant effects of alcohol in mice selectively bred for high and low alcohol preference.

  Behavioural pharmacology 20011101

• Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain.

  Alcoholism, clinical and experimental research 20010901

• Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.

  Alcoholism, clinical and experimental research 20010901

• [Adjuvant drug treatment of alcoholism with acamprosate: between sectoral budgets and disease management].

  Deutsche medizinische Wochenschrift (1946) 20010817

• Does the alcoholic's remedy come in a pill?

  Behavioral healthcare tomorrow 20010801

• Combined behavioral and pharmacologic treatments of alcoholism.

  American clinical laboratory 20010701

• The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

  Neuropharmacology 20010501

• Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials.

  Alcoholism, clinical and experimental research 20010501

• Mechanisms of alcohol-nicotine interactions: alcoholics versus smokers.

  Alcoholism, clinical and experimental research 20010501

• Naltrexone and acamprosate. Using new drugs for alcohol dependence.

  Australian family physician 20010501

• Effects of acamprosate on ethanol-seeking and self-administration in the rat.

  Alcoholism, clinical and experimental research 20010301

• Can this pill stop you from hitting the bottle?

  Newsweek 20010212

• Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption.

  Alcohol (Fayetteville, N.Y.) 20010201

• The European acamprosate trials: conclusions for research and therapy.

  Journal of biomedical science 20010101

• Neurotoxic effect of acamprosate, n-acetyl-homotaurine, in cultured neurons.

  Journal of biomedical science 20010101

• New developments in the pharmacotherapy of alcohol dependence.

  The American journal on addictions 20010101

• Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20010101

• Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20010101

• Pharmacologic approaches to the management of alcoholism.

  The Journal of clinical psychiatry 20010101

• Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.

  The Journal of clinical psychiatry 20010101

• Effects of acamprosate and scopolamine on the working memory of rats in a three-panel runway task.

  Journal of basic and clinical physiology and pharmacology 20010101

• [The neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia. A study with the lipid peroxidase inhibitor u-101033e].

  Der Anaesthesist 20000901

• Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.

  Drugs 19970601

• Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics.

  Lancet (London, England) 19850504